Microvascular function/dysfunction downstream a coronary stenosis

Current Pharmaceutical Design

Volumn 19, Issue 13, 2013, Pages 2366-2374

  Guarini, Giacinta ^a   Capozza, Paola Giuseppina ^a   Huqi, Alda ^a   Morrone, Doralisa ^a   Chilian, William M ^b   Marzilli, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Coronary microcirculation; Coronary stenosis; Endothelial dysfunction; Myocardial ischemia

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; VASOACTIVE AGENT;

ANGIOPLASTY; ARTIFICIAL EMBOLISM; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR AUTOREGULATION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; CORONARY VASCULAR RESISTANCE; DEPHOSPHORYLATION; EXERCISE; FRACTIONAL FLOW RESERVE; HEART CYCLE; HEART LEFT VENTRICLE WALL; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART PERFORMANCE; HEART RATE; HUMAN; MICROANGIOPATHY; MICROCIRCULATION; PERFUSION PRESSURE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SHEAR STRESS; SYSTOLIC BLOOD PRESSURE; UNSTABLE ANGINA PECTORIS; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CORONARY STENOSIS; CORONARY VESSELS; HUMANS; MICROVESSELS; REGIONAL BLOOD FLOW; STRESS, PHYSIOLOGICAL;

EID: 84877796491     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319130004     Document Type: Review

References (88)

1. Gould KL, Lipscomb K, Calvert C. Compensatory changes of the distal coronary vascular bed during progressive coronary constriction. Circulation 1975; 51(6): 1085-94.
2. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974; 33(1): 87-94.
3. Kuo L, Davis MJ, Chilian WM. Endothelium-dependent, flowinduced dilation of isolated coronary arterioles. Am J Physiol 1990; 259(4 Pt 2): H1063-70.
4. Picchi A, Limbruno U, Focardi M, et al. Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients. Am J Physiol Heart Circ Physiol.; 301(6): H2279-84.
5. Picchi A, Capobianco S, Qiu T, et al. Coronary microvascular dysfunction in diabetes mellitus: A review. World J Cardiol. 26; (11): 377-90.
6. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356(8): 830-40.
7. Feigl EO. Coronary physiology. Physiol Rev 1983; 63(1): 1-205.
8. Chilian WM. Microvascular pressures and resistances in the left ventricular subepicardium and subendocardium. Circ Res 1991; 69(3): 561-70.
9. Chilian WM, Eastham CL, Marcus ML. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol 1986; 251(4 Pt 2): H779-88.
10. Jones CJ, Kuo L, Davis MJ, et al. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 1995; 29(5): 585-96.
11. Deussen A, Ohanyan V, Jannasch A, et al. Mechanisms of metabolic coronary flow regulation. J Mol Cell Cardiol.; 52(4): 794-801.
12. Tune JD, Gorman MW, Feigl EO. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 2004; 97(1): 404-15.
13. Saitoh S, Kiyooka T, Rocic P, et al. Redox-dependent coronary metabolic dilation. Am J Physiol Heart Circ Physiol 2007; 293(6): H3720-5.
14. Yada T, Shimokawa H, Hiramatsu O, et al. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 2003; 107(7): 1040-5.
15. Koller A, Bagi Z. Nitric oxide and H2O2 contribute to reactive dilation of isolated coronary arterioles. Am J Physiol Heart Circ Physiol 2004; 287(6): H2461-7.
16. Headrick J, Willis RJ. Contribution of adenosine to changes in coronary flow in metabolically stimulated rat heart. Can J Physiol Pharmacol 1988; 66(2): 171-3.
17. Duncker DJ, van Zon NS, Pavek TJ, et al. Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockade. J Clin Invest 1995; 95(1): 285-95.
18. Ishibashi Y, Duncker DJ, Zhang J, et al. ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 1998; 82(3): 346-59.
19. Lavallee M, Takamura M, Parent R, et al. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev 2001; 6(4): 265-76.
20. Hecker M, Fleming I, Busse R. Kinin-mediated activation of endothelial no formation: possible role during myocardial ischemia. Agents Actions Suppl 1995; 45: 119-27.
21. Sato A, Sakuma I, Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 2003; 285(6): H2345-54.
22. Rogers PA, Dick GM, Knudson JD, et al. H2O2-induced redoxsensitive coronary vasodilation is mediated by 4-aminopyridinesensitive K+ channels. Am J Physiol Heart Circ Physiol 2006; 291(5): H2473-82.
23. Kokusho Y, Komaru T, Takeda S, et al. Hydrogen peroxide derived from beating heart mediates coronary microvascular dilation during tachycardia. Arterioscler Thromb Vasc Biol 2007; 27(5): 1057-63.
24. Kanatsuka H, Sekiguchi N, Sato K, et al. Microvascular sites and mechanisms responsible for reactive hyperemia in the coronary circulation of the beating canine heart. Circ Res 1992; 71(4): 912-22.
25. Kanatsuka H, Lamping KG, Eastham CL, et al. Heterogeneous changes in epimyocardial microvascular size during graded coronary stenosis. Evidence of the microvascular site for autoregulation. Circ Res 1990; 66(2): 389-96.
26. DeFily DV, Chilian WM. Coronary microcirculation: autoregulation and metabolic control. Basic Res Cardiol 1995; 90(2): 112-8.
27. Chilian WM, Layne SM. Coronary microvascular responses to reductions in perfusion pressure. Evidence for persistent arteriolar vasomotor tone during coronary hypoperfusion. Circ Res 1990; 66(5): 1227-38.
28. Kuo L, Davis MJ, Chilian WM. Myogenic activity in isolated subepicardial and subendocardial coronary arterioles. Am J Physiol 1988; 255(6 Pt 2): H1558-62.
29. Boatwright RB, Downey HF, Bashour FA, et al. Transmural variation in autoregulation of coronary blood flow in hyperperfused canine myocardium. Circ Res 1980; 47(4): 599-609.
30. Miller FJ, Jr., Dellsperger KC, Gutterman DD. Myogenic constriction of human coronary arterioles. Am J Physiol 1997; 273(1 Pt 2): H257-64.
31. Nowicki PT, Flavahan S, Hassanain H, et al. Redox signaling of the arteriolar myogenic response. Circ Res 2001; 89(2): 114-6.
32. Meininger GA, Davis MJ. Cellular mechanisms involved in the vascular myogenic response. Am J Physiol 1992; 263(3 Pt 2): H647-59.
33. Folgering JH, Sharif-Naeini R, Dedman A, et al. Molecular basis of the mammalian pressure-sensitive ion channels: focus on vascular mechanotransduction. Prog Biophys Mol Biol 2008; 97(2-3): 180-95.
34. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 2004; 95(9): 922-9.
35. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82(1): 131-85.
36. Slish DF, Welsh DG, Brayden JE. Diacylglycerol and protein kinase C activate cation channels involved in myogenic tone. Am J Physiol Heart Circ Physiol 2002; 283(6): H2196-201.
37. Khan TA, Bianchi C, Ruel M, et al. Mitogen-activated protein kinase inhibition and cardioplegia-cardiopulmonary bypass reduce coronary myogenic tone. Circulation 2003; 108 Suppl 1: II348-53.
38. Wang SY, Friedman M, Franklin A, et al. Myogenic reactivity of coronary resistance arteries after cardiopulmonary bypass and hyperkalemic cardioplegia. Circulation 1995; 92(6): 1590-6.
39. Recchia FA, Senzaki H, Saeki A, et al. Pulse pressure-related changes in coronary flow in vivo are modulated by nitric oxide and adenosine. Circ Res 1996; 79(4): 849-56.
40. Ueeda M, Silvia SK, Olsson RA. Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res 1992; 70(6): 1296-303.
41. Kuo L, Chilian WM, Davis MJ. Interaction of pressure-and flowinduced responses in porcine coronary resistance vessels. Am J Physiol 1991; 261(6 Pt 2): H1706-15.
42. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91(5): 1314-9.
43. Miura H, Wachtel RE, Liu Y, et al. Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels. Circulation 2001; 103(15): 1992-8.
44. Miura H, Liu Y, Gutterman DD. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. Circulation 1999; 99(24): 3132-8.
45. Sato A, Miura H, Liu Y, et al. Effect of gender on endotheliumdependent dilation to bradykinin in human adipose microvessels. Am J Physiol Heart Circ Physiol 2002; 283(3): H845-52.
46. Beyar R, Sideman S. Time-dependent coronary blood flow distribution in left ventricular wall. Am J Physiol 1987; 252(2 Pt 2): H417-33.
47. Hoffman JI. Transmural myocardial perfusion. Prog Cardiovasc Dis 1987; 29(6): 429-64.
48. Stein PD, Sabbah HN, Marzilli M, et al. Comparison of the distribution of intramyocardial pressure across the canine left ventricular wall in the beating heart during diastole and in the arrested heart. Evidence of epicardial muscle tone during diastole. Circ Res 1980; 47(2): 258-67.
49. Marzilli M, Goldstein S, Sabbah HN, et al. Modulating effect of regional myocardial performance on local myocardial perfusion in the dog. Circ Res 1979; 45(5): 634-41.
50. Buckberg GD, Fixler DE, Archie JP, et al. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 1972; 30(1): 67-81.
51. Olivotto I, Girolami F, Sciagra R, et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol. 16; 58(8): 839-48.
52. Olivotto I, Cecchi F, Gistri R, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006; 47(5): 1043-8.
53. Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003; 349(11): 1027-35.
54. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent STsegment elevation: the Task Force on the Management of STSegment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29(23): 2909-45.
55. Zhao XQ, Theroux P, Snapinn SM, et al. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators. Circulation 1999; 100(15): 1609-15.
56. Gurbel PA, Galbut B, Bliden KP, et al. Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy). J Thromb Thrombolysis 2002; 14(3): 213-9.
57. Marzilli M, Sambuceti G, Testa R, et al. Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina. J Am Coll Cardiol 2002; 40(12): 2102-9.
58. Lipscomb K, Gould KL. Mechanism of the effect of coronary artery stenosis on coronary flow in the dog. Am Heart J. Jan 1975; 89(1): 60-7.
59. Hoffman JI, Buckberg GD. Pathophysiology of subendocardial ischaemia. Br Med J 1975; 1(5949): 76-9.
60. Sambuceti G, Marzilli M, Fedele S, et al. Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty. Circulation 2001; 103(19): 2352-60.
61. Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation.; 124(13): 1414-25.
62. Pepine CJ. Provoked coronary spasm and acute coronary syndromes. J Am Coll Cardiol 2008; 52(7): 528-30.
63. Sambuceti G, Marzullo P, Giorgetti A, et al. Global alteration in perfusion response to increasing oxygen consumption in patients with single-vessel coronary artery disease. Circulation 1994; 90(4): 1696-705.
64. Sambuceti G, Marzilli M, Marraccini P, et al. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation 1997; 95(12): 2652-9.
65. Marzilli M, Sambuceti G, Fedele S, et al. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol 2000; 35(2): 327-34.
66. Sambuceti G, Marzilli M, Mari A, et al. Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium. Am J Physiol Heart Circ Physiol 2005; 288(5): H2298-305.
67. Wilson RF, Laxson DD, Lesser JR, et al. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989; 1(8642): 807-11.
68. Uren NG, Crake T, Lefroy DC, et al. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol 1993; 21(3): 612-21.
69. Uren NG, Crake T, Lefroy DC, et al. Altered resistive vessel function after coronary angioplasty is not due to reduced production of nitric oxide. Cardiovasc Res 1996; 32(6): 1108-14.
70. Dupouy P, Aptecar E, Pelle G, et al. Early changes in coronary flow physiology after balloon angioplasty or stenting: a 24-hour Doppler flow velocity study. Catheter Cardiovasc Interv 2002; 57(2): 191-8.
71. Cuisset T, Hamilos M, Melikian N, et al. Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. J Am Coll Cardiol 2008; 51(11): 1060-5.
72. Marzilli M, Mariani M. Ischemia-reperfusion and microvascular dysfunction: implications for salvage of jeopardized myocardium and reduction of infarct size. Ital Heart J 2001; 2 Suppl 3: 40S-2.
73. Marzilli M, Orsini E, Marraccini P, et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000; 101(18): 2154-9.
74. Minamino T, Kitakaze M, Asanuma H, et al. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. J Clin Invest 1998; 101(8): 1643-53.
75. Leppaluoto J, Ruskoaho H. Endothelin peptides: biological activities, cellular signalling and clinical significance. Ann Med 1992; 24(3): 153-61.
76. Zeiher AM, Krause T, Schachinger V, et al. Impaired endotheliumdependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995; 91(9): 2345-52.
77. Koch KC, vom Dahl J, Kleinhans E, et al. Influence of a platelet GPIIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy. J Am Coll Cardiol 1999; 33(4): 998-1004.
78. Gorman MW, Sparks HV, Jr. Progressive coronary vasoconstriction during relative ischemia in canine myocardium. Circ Res 1982; 51(4): 411-20.
79. Hori M, Inoue M, Kitakaze M, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol 1986; 250(3 Pt 2): H509-18.
80. Golino P, Piscione F, Willerson JT, et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 1991; 324(10): 641-8.
81. Sambuceti G, L'Abbate A, Marzilli M. Why should we study the coronary microcirculation? Am J Physiol Heart Circ Physiol 2000; 279(6): H2581-4.
82. Quyyumi AA, Dakak N, Mulcahy D, et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 1997; 29(2): 308-17.
83. Taylor AJ, Al-Saadi N, Abdel-Aty H, et al. Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. Am Heart J 2006; 151(4): 891 e891-7.
84. Kusmic C, Lazzerini G, Coceani F, et al. Paradoxical coronary microcirculatory constriction during ischemia: a synergic function for nitric oxide and endothelin. Am J Physiol Heart Circ Physiol 2006; 291(4): H1814-21.
85. Dorge H, Neumann T, Behrends M, et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 2000; 279(6): H2587-92.
86. Sambuceti G, Marzilli M, Mari A, et al. Clinical evidence for myocardial derecruitment downstream from severe stenosis: pressure-flow control interaction. Am J Physiol Heart Circ Physiol 2000; 279(6): H2641-8.
87. Spyrou N, Khan MA, Rosen SD, et al. Persistent but reversible coronary microvascular dysfunction after bypass grafting. Am J Physiol Heart Circ Physiol 2000; 279(6): H2634-40.
88. Selvanayagam JB, Cheng AS, Jerosch-Herold M, et al. Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study. Circulation 2007; 116(13): 1458-64.